The assassination of UnitedHealthcare CEO Brian Thompson has exposed widespread frustration with for-profit health insurance, a system often marred by denied claims and high out-of-pocket costs.
Data shows insurance costs are rising far quicker than inflation, leading to a notable increase in patients' out-of-pocket expenses, often exacerbated by prior authorization schemes.
While attention often focuses on Big Pharma’s pricing, pharmacy benefit managers (PBMs)—the middlemen—play a crucial role in the prescription drug affordability crisis yet remain less scrutinized.
Corporate consolidation in the healthcare industry, particularly the merging of PBMs with insurance giants, complicates transparency and accountability, further driving up costs for patients.
Collection
[
|
...
]